Treatment Outcomes in a Decentralized Antiretroviral Therapy Program: A Comparison of Two Levels of Care in North Central Nigeria
Figure 3
(a) Line graph showing trend in median CD4 levels (cells/mm3) at baseline through 48 weeks of follow-up between patients at the prime and satellite sites in Jos, Nigeria. (b) Bar chart showing proportions of patients achieving undetectable viral load (<400 copies/mL) from 12 through 48 weeks of follow-up in patients at the prime and satellite sites in Jos, Nigeria.
